Vericel Corp Ord (VCEL)

Exchange
NASDAQ
Symbol
VCEL
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cell therapies for the sports medicine and severe burn care markets in the United States. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: October 1, 2025

  • Open
    31.33
  • High
    31.92
  • Low
    30.75
  • Close
    30.91
  • Volume
    699,489

Financial ratios

Dec 31, 2024